Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
about
Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian PerspectiveThe cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.Treatment costs of psoriasis in a tertiary-level clinic.Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece.How much of the productivity losses among psoriasis patients are due to psoriasis.A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy.Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.The costs of psoriasis medications.The burden of moderate to severe psoriasis: an overview.The economic burden of psoriasis: a systematic literature review.The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.Cost of illness of urothelial bladder cancer in ItalyReducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice.Use pattern and predictors of use of highly caffeinated energy drinks among South Korean adolescents: a study using the Health Belief Model.Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system.Health economics and the modern management of psoriasis.Use of health care services by patients with psoriasis: a population-based study.Psoriasis and comorbidities in a southern Brazilian population: a case-control study.Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis.Healthcare utilization and medical expenditure of Korean psoriasis patients: A descriptive result using a health insurance database.
P2860
Q26747639-30D2EEFF-4D13-43D4-AA99-07044BC92CA7Q33646654-65EB9AB6-3057-4E1A-A8C3-A0AF7D897B17Q33858767-7F2971F9-30C3-4662-83B2-381E126CFC09Q34076641-CCF68CBE-6693-4BCC-9B72-1E1AFDFE8DD3Q34351604-FA4587C3-13CB-4663-AC6C-253DE84F0728Q35155525-5A4AF1AB-C5DF-4FE0-A7CF-EE35BB5160CCQ35205458-9227B208-13A1-41AA-9C19-0DE7A6252DC9Q36083240-99EB1FF3-76F8-49D7-9BBE-3DB0A968FE11Q36247035-00F34696-9C5D-4699-B761-013330A02958Q37468355-AA7CAB40-49DA-4ADD-BB6C-BC5DC5C322A8Q38044995-29E4C7AB-B0EE-4566-8C77-7116676C576CQ38232792-15574E10-6001-4346-9580-53918CEBB517Q38612964-7B409D97-D555-466F-BBF4-5B099FFB738AQ38645796-6BB33ECD-340C-4305-B669-D36C9D3638BAQ39748220-71DE3998-64AB-4863-8CBE-0CD91E8A10FDQ40046329-656B939F-C9BE-40BC-A91F-E8E13ADBE7EFQ40539764-32393572-BF41-48E6-BB5B-11070E64779AQ42267581-51246BCC-D423-4E5D-B9AA-CA535BA31985Q42648167-9293EF80-F0C7-43CD-9EFE-E7BCF4408845Q46788607-7DA87647-EAAE-481B-B289-8DEE0123ED7BQ46839536-4DB3D9DE-6232-4DE0-93DB-74571986F5D1Q48245405-E2F48752-24D5-4433-BD5D-9E4DAD5D14DCQ53185478-DE1D504B-D410-4E50-962C-E5C97460D3FCQ55403632-31F97C64-F542-4FB8-AE6E-CE709DAAB8D1
P2860
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
@en
type
label
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
@en
prefLabel
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
@en
P2093
P2860
P356
P1476
Moderate and severe plaque psoriasis: cost-of-illness study in Italy.
@en
P2093
A Costanzo
A Di Cesare
Gf Altomare
Gl Colombo
S Chimenti
P2860
P304
P356
10.2147/TCRM.S2740
P577
2008-04-01T00:00:00Z